SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trillium Therapeutics
TRIL 20.36+2.0%Nov 26 2:56 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
ghmm
From: scaram(o)uche1/17/2018 10:54:03 AM
1 Recommendation   of 294
 
The company also announced that Eric Sievers, MD, has transitioned from Chief Medical Officer to Senior Clinical Advisor.

Unbelievable. One of biology's truly innovative projects, and just now Stiernholm decides that he hasn't got the correct person as CMO.

Dr. Jahns will focus on developing partnership opportunities between Trillium and potential collaborators

Ditto, Business Development. No foresight.



Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News